Early experience with ocrelizumab in denmark. A population-based registry study

Melinda Magyari; Luigi Pontieri; Morten Blinkenberg; Viktoria Papp; Peter Vestergaard Rasmussen; Jakob Schäfer; Jonas M. Berg; Matthias Kant; Henrik Kahr Mathiesen; Michael Broksgaard Jensen

doi:10.1177/1352458520974937

Early experience with ocrelizumab in denmark. A population-based registry study

Identifier:nobleid.org/w1/20260515/36D4AF9F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/36D4AF9F.svg?ark=w1%2F20260515%2F36D4AF9F)](https://nobleid.org/work/w1/20260515/36D4AF9F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Peter Vestergaard Rasmussen

Jakob Schäfer

Jonas M. Berg

Matthias Kant

Henrik Kahr Mathiesen

Michael Broksgaard Jensen

Claim authorship of this work

Early experience with ocrelizumab in denmark. A population-based registry study

Identifier:nobleid.org/w1/20260515/36D4AF9F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/36D4AF9F.svg?ark=w1%2F20260515%2F36D4AF9F)](https://nobleid.org/work/w1/20260515/36D4AF9F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Peter Vestergaard Rasmussen

Jakob Schäfer

Jonas M. Berg

Matthias Kant

Henrik Kahr Mathiesen

Michael Broksgaard Jensen

Claim authorship of this work